000 | 01283 a2200373 4500 | ||
---|---|---|---|
005 | 20250513102908.0 | ||
264 | 0 | _c19970114 | |
008 | 199701s 0 0 eng d | ||
022 | _a0920-3206 | ||
024 | 7 |
_a10.1007/BF02627958 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIliodromitis, E K | |
245 | 0 | 0 |
_aProtection from preconditioning can be reinstated at various reperfusion intervals. _h[electronic resource] |
260 |
_bCardiovascular drugs and therapy _cJul 1996 |
||
300 |
_a341-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aIschemic Preconditioning, Myocardial |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardial Infarction _xprevention & control |
650 | 0 | 4 |
_aMyocardial Ischemia _xphysiopathology |
650 | 0 | 4 | _aMyocardial Reperfusion |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 | _aRisk Assessment |
700 | 1 | _aPapadopoulos, C | |
700 | 1 | _aParaskevaidis, I A | |
700 | 1 | _aKyriakides, Z S | |
700 | 1 | _aFlessa, C | |
700 | 1 | _aKremastinos, D T | |
773 | 0 |
_tCardiovascular drugs and therapy _gvol. 10 _gno. 3 _gp. 341-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02627958 _zAvailable from publisher's website |
999 |
_c8869757 _d8869757 |